Revision History
The content of this novel is somewhat dynamic. After chapters are posted, they may undergo slight modification. Perhaps in response to feedback (very much appreciated!), or changes of heart, or to repair plot conflicts. Minor fixes are not noted here. Only the significant updates are summarized below:
Chapter 1. Posted July 23, 2025
August 9, 2025
Additions to Lydia's backstory.
August 17, 2025
Barista Pete makes a cameo.
Lydia states that the headshot on her website is not a likeness. It is AI-generated.
August 21, 2025
A corporate monolith is introduced: GigantoPharm.
Chapter 2. Posted August 25, 2025
Chapter 3. Posted September 1, 2025
September 3, 2025
Added: the significance of the GigantoPharm Cancer Prize.
September 24, 2025
Added: In response to Robbins' questioning, Agarwal provides more information on the conference at which Lydia has planned to interview him.
November 5, 2025
With Traci Weber being the focus of Chapter 6, it became necessary to add more backstory to her (professional) relationship with Chuck Standish.
November 28, 2025
Traci's sister arranges a visit.
December 16, 2025
Added: A description of Traci's appointment at the FIB. . .
January 17, 2026
. . . as Chair of the Cell Signaling Department, replacing Ted Worthington ("Ted the Head").
March 2, 2026
Added: Some difficulties that Traci encountered in her new position, which will be further elaborated in future chapters.
Chapter 4. Posted September 28, 2025
September 30, 2025
A more detailed phone conversation between Susan and Lydia.
October 5, 2025
A few paragraphs are rearranged, because Myra (Agarwal's wife) has more to contribute.
October 29, 2025
A restatement of Agarwal's role in organizing the New Orleans conference.
November 19, 2025
Agarwal's brother is briefly introduced.
Chapter 5. Posted December 28, 2025
December 29, 2025
Added: Traci Weber's family history
Chapter 6. Posted October 30, 2025 (originally posted as Chapter 5)
Chapter 7. Posted January 15, 2026
Chapter 8. Posted March 6, 2026
March 8, 2026
More information on the capability of GigantoPharm AI